Scleral Fixation of Akreos AO60 Intraocular Lens Using Gore-Tex Suture: An Eye on Visual Outcomes and Postoperative Complications
Table 2
Clinical outcomes.
Visual acuity
Preop. logMAR VA, mean ± SD
Postop. logMAR VA, mean ± SD
Overall (n = 37)
1.61 ± 0.73
0.57 ± 0.66
()
Surgical indication (n)
Aphakia due to complicated cataract surgery (9)
1.46 ± 0.68
0.51 ± 0.45
0.028
Subluxated IOL due to closed trauma (8)
1,65 ± 0.83
0.44 ± 0.76
0.028
Non-traumatic, non-PEX-related subluxated IOL (7)
1.61 ± 0.75
0.65 ± 0.66
0.028
PEX-related subluxated IOL (6)
1.47 ± 0.81
0.32 ± 0.25
0.043
Subluxated crystalline lens due to closed trauma (3)
2.08 ± 0.17
1.35 ± 1.08
0.317
Aphakia due to open-globe injury (2)
2.13 ± 0.21
1.09 ± 1.26
0.317
Silicone-induced IOL opacification (1)
0.15 ± 0.00
0.00 ± 0.00
†
Aphakia post-endophthalmitis (1)
2.28 ± 0.00
0.30 ± 0.00
†
Intraoperative complications
n (%)
Treatment
Iatrogenic retinal hole
1 (2.7%)
Endolaser
Choroidal detachment
1 (2.7%)
Observation
Vitreous hemorrhage
1 (2.7%)
Observation
Postoperative complications
n (%)
Treatment
Ocular hypertension
10 (27.0%)
Topical
Corneal edema
7 (18.9%)
Topical
Cystoid macular edema
7 (18.9%)
Topical + intravitreal injections
Hypotension
2 (5.4%)
Observation
Vitreous hemorrhage
1 (2.7%)
Observation
Central retinal vein occlusion
1 (2.7%)
Intravitreal injections
Retinal detachment
1 (2.7%)
Surgical
Akreos IOL opacification
1 (2.7%)
Surgical
PEX, pseudoexfoliation. †This subgroup includes 1 case, and a value is impossible to calculate. Five eyes with macular edema responded to topical nepafenac 3 mg/ml + dexamethasone 1 mg/ml drops; 2 eyes were refractory to topical drops and needed intravitreal injections of corticosteroids (1 case with intravitreal 2 mg triamcinolone alone, and the other with 2 mg triamcinolone, followed by 0.7 mg dexamethasone intravitreal implant).
